Quantcast

Latest Radiofrequency ablation Stories

2014-08-27 23:05:43

Transparency Market Research has published a new report titled "Ablation Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report database. Albany, New York (PRWEB) August 27, 2014 According to a new market report published by Transparency Market Research "Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency,...

2014-08-21 23:13:30

Dr. Lowell S. Kabnick, a vascular doctor in New Jersey, has found surprising examples of inequalities in health insurance guidelines for symptomatic varicose vein treatment, publishing the results of his study in a new journal article out this month. Morristown, NJ (PRWEB) August 21, 2014 Lowell S. Kabnick, MD, a practicing vascular doctor in New Jersey, has uncovered significant inequalities in health insurance guidelines governing coverage of treatment for symptomatic varicose veins....

2014-08-07 12:28:46

ALBANY, New York, August 7, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave, Cryotherapy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020," the global ablation technologies market was valued at USD...

2014-07-31 23:11:56

A new catheter being used by cardiologists at Baptist Heart Specialists is helping patients who have an abnormal heart rhythm. Jacksonville, Fla. (PRWEB) July 31, 2014 A new catheter being used by cardiologists at Baptist Heart Specialists is helping patients who have an abnormal heart rhythm. The THERMOCOOL® SmartTOUCH™ Catheter is used for ablation procedures for patients such as those suffering from atrial fibrillation (Afib). Cardiac electrophysiologists at Baptist Heart...

2014-07-28 08:29:13

Latest Data Sweep from a 285 Patient Subgroup Shows An Impressive 57% Improvement in Overall Survival LAWRENCEVILLE, N.J., July 28, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced updated results from its retrospective analysis of the Company's 701-patient HEAT Study of ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin, in combination with radiofrequency ablation (RFA) in primary liver cancer, also known as...

2014-07-23 12:31:26

DUBLIN, July 23, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Electrophysiology Ablation Catheters Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Catheter ablation is a minimally invasive procedure used to remove or destroy faulty electrical pathways from sections of the heart that promote irregular cardiac rhythms (also known as cardiac arrhythmias). Cardiac arrhythmias can be of several types, including...

2014-06-09 08:30:45

LONDON, June 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: U.S. Market for Cardiac Rhythm Managment, Electrophysiology and Ablationhttp://www.reportbuyer.com/pharma_healthcare/medical_devices/u_s_market_cardiac_rhythm_managment_electrophysiology_ablation.html In 2012, the U.S. market for cardiac rhythm management (CRM), electrophysiology and ablation devices market was valued at nearly $6.8 billion.The CRM, electrophysiology and ablation device...

2014-05-21 08:29:17

- On Track for Study Participation in Major HCC Markets Worldwide - LAWRENCEVILLE, N.J., May 21, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced it has received regulatory clearance to initiate its Phase III OPTIMA Study at clinical trial sites in Taiwan, Hong Kong, South Korea and Canada. The OPTIMA Study is the Company's planned global pivotal, double-blind, placebo-controlled study evaluating ThermoDox®, its proprietary heat-activated liposomal...

2014-05-16 12:27:07

TIANJIN, China, May 16, 2014 /PRNewswire/ -- Recently, TEDA International Cardiovascular Hospital (hereinafter referred to as "TEDA") successfully performed the cryoballoon ablation surgery of atrial fibrillation (AF) on two AF patients. It is reported that extremely few hospitals in China can make such operation and it is also the first time in Tianjin. The 61-year-old Granny Zhang, a paroxysmal AF patient who lives in the Tanggu district of Tianjin, has received the surgery....

2014-05-16 08:26:24

Abstract Presents a Retrospective Analysis of the Company's 701 Patient HEAT Study and Compelling Data Showing Enhanced Efficacy When Radiofrequency Ablation is Combined with ThermoDox and When Heating Time of the RFA Procedure is Greater Than 45 Minutes LAWRENCEVILLE, N.J., May 16, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that an abstract on its Phase III HEAT Study of ThermoDox, the Company's proprietary...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related